These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 50967)

  • 1. Studies on delayed hypersensitivity of patients with Hodgkin's disease during remission.
    Petrov M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(1):35-9. PubMed ID: 50967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptive transfer of cell-mediated immunity to tuberculin using RNA from tuberculin-sensitive subjects.
    Han T; Pauly JL; Mittelman A
    Immunology; 1975 Jan; 28(1):127-32. PubMed ID: 1116867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status).
    Libánský J; Lukásová M; Pinosová I
    Neoplasma; 1973; 20(1):51-60. PubMed ID: 4702205
    [No Abstract]   [Full Text] [Related]  

  • 5. The absence of lymphocyte response in vitro to tuberculin challenge in Hodgkin's disease.
    Sartoris S; Cavallero P; Pegoraro L; Vergnano F; Fazio M
    Panminerva Med; 1965 Oct; 7(10):370-2. PubMed ID: 5844508
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitation of immunocompetence in Hodgkin's disease.
    Faguet GB
    J Clin Invest; 1975 Oct; 56(4):951-7. PubMed ID: 1159096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
    Fuks Z; Strober S; Kaplan HS
    N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphocyte transformation caused by PHA and PPD in patients with Hodgkin's disease and its correlation with clinical and hematological aspects].
    Tognella S; Mantovani G; Malloci A; Del Giacco GS; Manconi PE; Grifoni V
    Haematologica; 1972; 57(9):552-5. PubMed ID: 4199311
    [No Abstract]   [Full Text] [Related]  

  • 9. [Delayed hypersensitivity in Hodgkin's disease].
    Del Giacco GS; Manconi PE; Tognella S; Mantovani G; Grifoni V
    Boll Soc Ital Biol Sper; 1972 Jul; 48(14):377-81. PubMed ID: 4563128
    [No Abstract]   [Full Text] [Related]  

  • 10. Improvement in delayed hypersensitivity in Hodgkin's disease with transfer factor: lymphapheresis and cellular immune reactions or normal donors.
    Khan A; Hill JM; MacLellan A; Loeb E; Hill NO; Thaxton S
    Cancer; 1975 Jul; 36(1):86-9. PubMed ID: 1081903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hodgkin's disease: study of delayed hypersensitivity of 64 non treated patients. Value of epicutaneous test using croton oil].
    Goasguen J; Leblay R; Guerin D; Le Prise PY; Richier JL
    Sem Hop; 1977 Jan; 53(4):219-25. PubMed ID: 189435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Persisting deficiency of cell mediated immunity in Hodgkin's disease in complete remission (author's transl)].
    Lang JM; Bigel P; Giron C; Faradji A; Oberling F; Mayer S
    Nouv Presse Med; 1979 Nov; 8(44):3629-32. PubMed ID: 316521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degrees of impairment of cell-mediated immune reactivity in Hodgkin's disease.
    Petrov M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(2):201-10. PubMed ID: 61913
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum zinc levels, lymphocyte counts and functions in pediatric Hodgkin's disease.
    Babacan E; Cavdar AO; Arcasoy A
    Boll Ist Sieroter Milan; 1977 Jul; 56(3):228-34. PubMed ID: 901636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte function in anergic patients.
    Rode HN; Christou NV; Bubenik O; Superina R; Gordon J; Meakins JL; MacLean LD
    Clin Exp Immunol; 1982 Jan; 47(1):155-61. PubMed ID: 6212172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
    Churchill WH; Rocklin RR; Moloney WC; David JR
    Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
    [No Abstract]   [Full Text] [Related]  

  • 17. Impaired delayed-hypersensitivity responses in 154 patients with untreated Hodgkin's disease.
    Eltringham JR; Kaplan HS
    Natl Cancer Inst Monogr; 1973 May; 36():107-15. PubMed ID: 4582989
    [No Abstract]   [Full Text] [Related]  

  • 18. Spontaneous lymphocyte proliferation and depressed cellular immunity in Hodgkin's disease.
    Shiftan TA; Caviles AP; Mendelsohn J
    Clin Exp Immunol; 1978 Apr; 32(1):144-52. PubMed ID: 668190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune function of successfully treated lymphoma patients.
    King GW; Yanes B; Hurtubise PE; Balcerzak SP; LoBuglio AF
    J Clin Invest; 1976 Jun; 57(6):1451-60. PubMed ID: 932190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persisting lymphocyte deficiences during remission in Hodgkin's disease.
    Björkholm M; Holm G; Mellstedt H
    Clin Exp Immunol; 1977 Jun; 28(3):389-93. PubMed ID: 302164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.